155 related articles for article (PubMed ID: 11448840)
1. 2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.
Hou X; Roberts LJ; Taber DF; Morrow JD; Kanai K; Gobeil F; Beauchamp MH; Bernier SG; Lepage G; Varma DR; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R391-400. PubMed ID: 11448840
[TBL] [Abstract][Full Text] [Related]
2. Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels.
Hou X; Gobeil F; Peri K; Speranza G; Marrache AM; Lachapelle P; Roberts J; Varma DR; Chemtob S; Ellis EF
Stroke; 2000 Feb; 31(2):516-24; discussion 525. PubMed ID: 10657431
[TBL] [Abstract][Full Text] [Related]
3. Response of rat thoracic aorta to F(2)-isoprostane metabolites.
Cracowski JL; Camus L; Durand T; Devillier P; Guy A; Hardy G; Stanke-Labesque F; Rossi JC; Bessard G
J Cardiovasc Pharmacol; 2002 Mar; 39(3):396-403. PubMed ID: 11862119
[TBL] [Abstract][Full Text] [Related]
4. Isomer-specific contractile effects of a series of synthetic f2-isoprostanes on retinal and cerebral microvasculature.
Hou X; Roberts LJ; Gobeil F; Taber D; Kanai K; Abran D; Brault S; Checchin D; Sennlaub F; Lachapelle P; Varma D; Chemtob S
Free Radic Biol Med; 2004 Jan; 36(2):163-72. PubMed ID: 14744628
[TBL] [Abstract][Full Text] [Related]
5. Contractile effects of 15-E2t-isoprostane and 15-F2t-isoprostane on chicken embryo ductus arteriosus.
van der Sterren S; Villamor E
Comp Biochem Physiol A Mol Integr Physiol; 2011 Aug; 159(4):436-44. PubMed ID: 21565280
[TBL] [Abstract][Full Text] [Related]
6. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay.
Morales CR; Terry ES; Zackert WE; Montine TJ; Morrow JD
Clin Chim Acta; 2001 Dec; 314(1-2):93-9. PubMed ID: 11718683
[TBL] [Abstract][Full Text] [Related]
7. Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)].
Cracowski JL; Stanke-Labesque F; Devillier P; Chavanon O; Hunt M; Souvignet C; Bessard G
Eur J Pharmacol; 2000 May; 397(1):161-8. PubMed ID: 10844110
[TBL] [Abstract][Full Text] [Related]
8. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.
Dorjgochoo T; Gao YT; Chow WH; Shu XO; Yang G; Cai Q; Rothman N; Cai H; Li H; Deng X; Franke A; Roberts LJ; Milne G; Zheng W; Dai Q
Am J Clin Nutr; 2012 Aug; 96(2):405-14. PubMed ID: 22760572
[TBL] [Abstract][Full Text] [Related]
9. Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia.
Wilson SH; Best PJ; Lerman LO; Holmes DR; Richardson DM; Lerman A
Cardiovasc Res; 1999 Dec; 44(3):601-7. PubMed ID: 10690293
[TBL] [Abstract][Full Text] [Related]
10. Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations.
Sametz W; Hennerbichler S; Glaser S; Wintersteiger R; Juan H
Br J Pharmacol; 2000 Aug; 130(8):1903-10. PubMed ID: 10952681
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels.
Lahaie I; Hardy P; Hou X; Hasséssian H; Asselin P; Lachapelle P; Almazan G; Varma DR; Morrow JD; Roberts LJ; Chemtob S
Am J Physiol; 1998 May; 274(5):R1406-16. PubMed ID: 9612409
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological actions of isoprostane metabolites and phytoprostanes in human and bovine pulmonary smooth muscles.
Liu C; Tazzeo T; Guy A; Durand T; Janssen LJ
Prostaglandins Leukot Essent Fatty Acids; 2007 Jan; 76(1):57-64. PubMed ID: 17049219
[TBL] [Abstract][Full Text] [Related]
13. Temperature-dependent basal tone in isolated human saphenous veins: implication of TP-receptors.
Simonet S; Bonhomme E; Fabiani JN; Verbeuren T
Fundam Clin Pharmacol; 2000; 14(5):461-7. PubMed ID: 11129086
[TBL] [Abstract][Full Text] [Related]
14. Isoprostanes constrict human radial artery by stimulation of thromboxane receptors, Ca2+ release, and RhoA activation.
Mueed I; Tazzeo T; Liu C; Pertens E; Zhang Y; Cybulski I; Semelhago L; Noora J; Lamy A; Teoh K; Chu V; Janssen LJ
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):131-8. PubMed ID: 18179929
[TBL] [Abstract][Full Text] [Related]
15. 15-F(2t)-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts.
Xia Z; Kuo KH; Godin DV; Walker MJ; Tao MC; Ansley DM
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1366-72. PubMed ID: 15937102
[TBL] [Abstract][Full Text] [Related]
16. Dominant role for calpain in thromboxane-induced neuromicrovascular endothelial cytotoxicity.
Quiniou C; Sennlaub F; Beauchamp MH; Checchin D; Lahaie I; Brault S; Gobeil F; Sirinyan M; Kooli A; Hardy P; Pshezhetsky A; Chemtob S
J Pharmacol Exp Ther; 2006 Feb; 316(2):618-27. PubMed ID: 16214879
[TBL] [Abstract][Full Text] [Related]
17. Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.
Marlière S; Cracowski JL; Hakim A; Stanke-Labesque F; Hoffmann P; Bessard G
Can J Physiol Pharmacol; 2005 Jun; 83(6):453-8. PubMed ID: 16049544
[TBL] [Abstract][Full Text] [Related]
18. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
[TBL] [Abstract][Full Text] [Related]
19. The effects of oxidation products of arachidonic acid and n3 fatty acids on vascular and platelet function.
Barden A; Mas E; Henry P; Durand T; Galano JM; Roberts LJ; Croft KD; Mori TA
Free Radic Res; 2011 Apr; 45(4):469-76. PubMed ID: 21235285
[TBL] [Abstract][Full Text] [Related]
20. The 5-series F(2)-isoprostanes possess no vasomotor effects in the rat thoracic aorta, the human internal mammary artery and the human saphenous vein.
Marlière S; Cracowski JL; Durand T; Chavanon O; Bessard J; Guy A; Stanke-Labesque F; Rossi JC; Bessard G
Br J Pharmacol; 2002 Mar; 135(5):1276-80. PubMed ID: 11877336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
